NO951147D0 - Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel - Google Patents
Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddelInfo
- Publication number
- NO951147D0 NO951147D0 NO951147A NO951147A NO951147D0 NO 951147 D0 NO951147 D0 NO 951147D0 NO 951147 A NO951147 A NO 951147A NO 951147 A NO951147 A NO 951147A NO 951147 D0 NO951147 D0 NO 951147D0
- Authority
- NO
- Norway
- Prior art keywords
- drug
- preparation
- carboxylic acid
- acid esters
- substituted heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4410453A DE4410453A1 (de) | 1994-03-25 | 1994-03-25 | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO951147D0 true NO951147D0 (no) | 1995-03-24 |
| NO951147L NO951147L (no) | 1995-09-26 |
Family
ID=6513880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951147A NO951147L (no) | 1994-03-25 | 1995-03-24 | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0673930A1 (no) |
| JP (1) | JPH07278111A (no) |
| KR (1) | KR950032127A (no) |
| AU (1) | AU1504495A (no) |
| CA (1) | CA2145473A1 (no) |
| CZ (1) | CZ73595A3 (no) |
| DE (1) | DE4410453A1 (no) |
| FI (1) | FI951388A (no) |
| HU (1) | HUT72596A (no) |
| NO (1) | NO951147L (no) |
| PL (1) | PL307846A1 (no) |
| ZA (1) | ZA952410B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0206711D0 (en) | 2002-03-21 | 2002-05-01 | Isis Innovation | HIF Inhibitor |
| US7915443B2 (en) * | 2006-11-16 | 2011-03-29 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
| US8558002B2 (en) | 2006-11-16 | 2013-10-15 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
| TWI735416B (zh) | 2014-10-06 | 2021-08-11 | 美商維泰克斯製藥公司 | 囊腫纖維化症跨膜傳導調節蛋白之調節劑 |
| PL3436446T3 (pl) | 2016-03-31 | 2023-09-11 | Vertex Pharmaceuticals Incorporated | Modulatory mukowiscydozowego przezbłonowego regulatora przewodnictwa |
| CN109803962B (zh) | 2016-09-30 | 2022-04-29 | 弗特克斯药品有限公司 | 囊性纤维化跨膜传导调控蛋白的调节剂、以及药物组合物 |
| MA54847A (fr) | 2016-12-09 | 2021-12-08 | Vertex Pharma | Forme crystalline d'un n-(pyrazol-4-yl)sulfonyl-6-(pyrazol-1-yl)-2-(pyrrolidin-1-yl)pyridine-3-carboxamide pour traiter la mucoviscidose |
| EP3634402A1 (en) | 2017-06-08 | 2020-04-15 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
| WO2019018395A1 (en) | 2017-07-17 | 2019-01-24 | Vertex Pharmaceuticals Incorporated | METHODS OF TREATING CYSTIC FIBROSIS |
| ES2912657T3 (es) | 2017-08-02 | 2022-05-26 | Vertex Pharma | Procesos para preparar compuestos de pirrolidina |
| AU2018351533B2 (en) | 2017-10-19 | 2023-02-02 | Vertex Pharmaceuticals Incorporated | Crystalline forms and compositions of CFTR modulators |
| KR20200097293A (ko) | 2017-12-08 | 2020-08-18 | 버텍스 파마슈티칼스 인코포레이티드 | 낭포성 섬유증 막횡단 전도 조절자의 조정제의 제조 방법 |
| TWI810243B (zh) | 2018-02-05 | 2023-08-01 | 美商維泰克斯製藥公司 | 用於治療囊腫纖化症之醫藥組合物 |
| US11414439B2 (en) | 2018-04-13 | 2022-08-16 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-03-25 DE DE4410453A patent/DE4410453A1/de not_active Withdrawn
-
1995
- 1995-03-09 EP EP95103405A patent/EP0673930A1/de not_active Withdrawn
- 1995-03-23 FI FI951388A patent/FI951388A/fi unknown
- 1995-03-23 CZ CZ95735A patent/CZ73595A3/cs unknown
- 1995-03-23 AU AU15044/95A patent/AU1504495A/en not_active Abandoned
- 1995-03-24 ZA ZA952410A patent/ZA952410B/xx unknown
- 1995-03-24 NO NO951147A patent/NO951147L/no unknown
- 1995-03-24 JP JP7065927A patent/JPH07278111A/ja active Pending
- 1995-03-24 CA CA002145473A patent/CA2145473A1/en not_active Abandoned
- 1995-03-24 PL PL95307846A patent/PL307846A1/xx unknown
- 1995-03-24 HU HU9500863A patent/HUT72596A/hu unknown
- 1995-03-25 KR KR1019950006806A patent/KR950032127A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO951147L (no) | 1995-09-26 |
| CA2145473A1 (en) | 1995-09-26 |
| ZA952410B (en) | 1995-12-01 |
| HUT72596A (en) | 1996-05-28 |
| EP0673930A1 (de) | 1995-09-27 |
| DE4410453A1 (de) | 1995-09-28 |
| KR950032127A (ko) | 1995-12-20 |
| FI951388A0 (fi) | 1995-03-23 |
| FI951388A (fi) | 1995-09-26 |
| CZ73595A3 (en) | 1995-11-15 |
| JPH07278111A (ja) | 1995-10-24 |
| PL307846A1 (en) | 1995-10-02 |
| AU1504495A (en) | 1995-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO984877D0 (no) | Substituerte isokinolin-3-karboksylsyreamider, deres fremstilling og deres anvendelse som legemiddel | |
| NO963499D0 (no) | Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav | |
| NO20013736L (no) | Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme | |
| NO933647D0 (no) | Karboksylsyrederivater, legemidler inneholdende disse og fremgangsmaae for deres fremstilling | |
| NO20002217L (no) | Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler | |
| DK617388D0 (da) | Substituerede carboxylsyrederivater, deres fremstiilling og anvendelse som fungicider | |
| NO991761D0 (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
| NO951147D0 (no) | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel | |
| FI954007A (fi) | Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena | |
| DK399789A (da) | Annellerede tetrahydropyridineddikesyrederivater, deres fremstilling og anvendelse | |
| DK482688D0 (da) | Substituerede 2-phenyl-4-quinolin-carboxylsyrer og deres anvendelse som laegemidler | |
| NO984714L (no) | Nye karboksylsyre-derivater, deres fremstilling og anvendelse | |
| NO984713L (no) | Nye karboksylsyre-derivater, deres fremstilling og anvendelse | |
| FI960634A0 (fi) | Uusia kinolonikarboksyylihappojohdannaisia | |
| DK0410358T3 (da) | Aromatiske carboxylsyreamider, deres fremstilling og deres anvendelse som lægemidler | |
| NO940130D0 (no) | Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav | |
| DK165552C (da) | Carboxylsyreestere, deres fremstilling og anvendelse som insecticider | |
| NO981002D0 (no) | Karboksylsyrederivater, deres fremstilling og anvendelse | |
| NO940844D0 (no) | Farmasöytisk aktive hydroksykarboksylsyrederivater | |
| DK513188A (da) | Aminosyreestre, deres fremstilling og anvendelse som laegemidler | |
| DK1157020T3 (da) | Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel | |
| NO951148D0 (no) | Substituerte heterocykliske karboksylsyreamider, deres fremstilling og deres anvendelse som legemiddel | |
| NO980994D0 (no) | Substituerte fosfinsyreforbindelser og deres anvendelse som farmasöytika | |
| NO955325D0 (no) | Propansyrederivater, deres fremstilling og terapeutiske anvendelse | |
| DK0862550T3 (da) | Hidtil ukendte carboxylsyrederivater, deres fremstilling og anvendelse |